FARO ECONÓMICOSTOCK ANALYSIS

LDOS — analysis and forecast

$144.16+0.8% todayLeidos Holdings, Inc.
Verdict
Strongly bullish
RSI (14)
99
MACD
▲ rising
Trend
Uptrend
Volatility
36%
52w range
44%

🔢 What the numbers say

The last 12 months, in plain words

🗓️ Forecast by horizon

Directional bias · probability of rising · expected price and likely range (68%)

HorizonBiasProb. upExpected price68% range
1 dayStrongly bullish60%$144.09 -0.1%$140.87 – $147.38
3 daysStrongly bullish59%$143.94 -0.2%$138.42 – $149.68
1 weekStrongly bullish59%$143.79 -0.3%$136.71 – $151.23
15 daysStrongly bullish57%$143.42 -0.5%$133.54 – $154.03
1 monthBullish54%$142.61 -1.1%$128.60 – $158.16
3 monthsBullish49%$139.57 -3.2%$116.67 – $166.95

Recent momentum: +20.7% over 20 days · +4.8% over 60 days. The further out the horizon, the wider and more uncertain the forecast.

📈 Probability cone

📜 LDOS government contracts

The public money behind this company — the "Follow the Contract" pattern.

Defense Health Agency$318 M
New award · official · Oct 13, 2026

Leidos Inc., Reston, Virginia, was awarded a $317,986,855 firm-fixed-price contract to provide essential system reintegration, software licensing, and hosting services for the electronic health record system known as MHS GENESIS.

💡 Worth 1.81% of the company's market value. Stock since the announcement: +16.8%.

Health & Human Services$342 M
Modification · official · Sep 30, 2026

Nci operational task order, fy26-fy27

💡 Worth 1.95% of the company's market value. Firm money at signing: $342 M. Stock since the announcement: +14.8%.

Health & Human Services$72 M
New award · official · Sep 29, 2026

Functional precision medicine and response assays

💡 Worth 0.41% of the company's market value. Firm money at signing: $72 M. Stock since the announcement: +13.6%.

📚 Go deeper: Faro Library reports

PDF reports built from official filings. Your first one is free, no email; then $1.99 each or all 33 for $25 — included in Navigator and Admiral.

See all 33 reports →

❓ Frequently asked questions about LDOS

How much has LDOS fallen in the last year?

Leidos (LDOS) is down 24.5% over the last 12 months and trades at $144.16, 27.8% below its 52-week high ($199.55). 52-week range: $100.00 – $199.55.

How volatile is LDOS stock?

Its annualized volatility is around 36% and its worst drop from a peak over the last year was 49.9%. For reference, the S&P 500 usually moves 15–20% a year.

Does LDOS have U.S. government contracts?

Yes. Faro's register lists 3 contracts; the most recent: Defense Health Agency, $318 M, Oct 13, 2026.

Is now a good time to buy LDOS?

Nobody can know that for sure and this page is not a buy recommendation. What the data shows today: strongly bullish technical bias, RSI 99 (overbought zone), price above its 50-day average and an estimated 54% probability of being higher in 1 month. Use it as a starting point for research, not as a signal.

🧠 How it is calculated

The verdict combines trend (20/50/200 moving averages), momentum (RSI, MACD), mean reversion (Bollinger Bands), conviction (volume) and historical drift, weighted differently for each horizon. Uncertainty is modeled with a lognormal probability cone (geometric Brownian motion). This is statistical analysis, not a crystal ball.

🔦 Keep analyzing

Other stocks Faro watches

🔮 Oracle Pro 📈 Trading Room 📅 Calendar

⚠️ Educational tool. Not financial advice. Forecasts are statistical estimates based on historical volatility; the market can do the opposite. Data via Yahoo Finance. Always verify before trading. The decisions are yours.